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Introduction: The aims of this study were to establish and assess the 
utility of Power/Color Doppler-mode vascular image pattern classifi-
cation of lymph nodes (LN) during mediastinal staging by endobron-
chial ultrasound (EBUS) for the prediction of metastasis in patients 
with lung cancer.
Methods: one hundred and seventy-three LNs were retrospectively 
evaluated. The convex probe EBUS was used with the endoscopic 
ultrasound scanner. The vascular image patterns were graded as 
follows: Grade 0, no blood flow or small amounts of flow; Grade I, a 
few main vessels running toward the center of the LN from the hilum; 
Grade II, a few punctiforms or rod-shaped flow signals or a few small 
vessels found as a long strip of a curve; and Grade III, rich flow, more 
than four vessels found with different diameters or twist- or helical -low 
signal. The blood flow from the bronchial artery (BA) toward the 
LN was also recorded using Color Doppler imaging as a sign for 
BA inflow. 
Results: When we defined Grade 0 and I as “benign” and Grade 
II and III as “malignant,” the sensitivity, specificity, and diagnostic 
accuracy rate were 87.7%, 69.6%, and 78.0%, respectively. The accu-
racy of predicting metastasis solely from a positive BA inflow sign 
was 80.3%. of the LNs, 84.5% were shown to be metastatic when 
they were determined as malignant, and 84.7%  were proven non-
metastatic when it was determined as benign.
Conclusions: Vascular image patterns of LN using Power/Color 
Doppler mode is helpful in the prediction of metastatic LN during 
EBUS-TBNA.
Key Words: Doppler ultrasound imaging, Interventional ultrasound, 
Lymphatic metastasis.
(J Thorac Oncol. 2012;7: 1009–1014)
Endobronchial-ultrasound–guided transbronchial needle aspiration (EBUS-TBNA) is a minimally invasive modal-
ity with a high diagnostic yield for mediastinal staging of 
non–small-cell lung cancer.1–4 We have previously reported 
on a standard EBUS-image classification system of LNs5 and 
shown its usefulness for the prediction of nonmetastatic LNs. 
This raises the possibility of reducing unnecessary biopsies 
during mediastinal staging by using EBUS-TBNA.
The second-generation convex probe (CP)-EBUS is com-
patible with connecting to several kinds of high-quality ultrasound 
scanners. As a result of the increased frequency of the ultrasound 
from 7.5 MHz to 10 MHz, the quality of the imaging has been 
much improved, which allows better evaluation of the vascular 
structures using the Power Doppler mode. Color Doppler obser-
vation is also possible with this configuration, which allows iden-
tification of the direction of blood flow during the examination.6 
Vascular changes seen in metastatic lymph nodes (LNs) have 
been reported to be observed as an absence of central intranodal 
blood vessels by endoscopic ultrasound.6 The vascular structure 
of the normal LN is distorted by tumor infiltration and neovas-
cularization in metastatic LNs.7 Power/color Doppler ultrasound 
images have been used for the assessment of lymphadenopathy in 
several organs and can be used to distinguish between metastatic 
and nonmetastatic LN in patients with malignant diseases.8–11 
Indeed, identification of metastatic LNs may possibly be detected 
by EBUS simply with Doppler-mode imaging.6 The aims of this 
study were to establish the Doppler-mode vascular image pattern 
classification of LN during EBUS-TBNA, and to assess its utility 
for the prediction of metastatic LNs.
MATERIALS AND METHODS
Study Subjects
From April 2009 to october 2009, EBUS images from 
patients diagnosed with lung cancer who underwent EBUS-
TBNA for mediastinal staging were retrospectively reviewed. 
Mediastinal and hilar LNs observed using the CP-EBUS 
with Doppler mode during EBUS-TBNA were evaluated. 
The Doppler-mode–observed LNs were randomly selected 
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during EBUS-TBNA. Patients who were diagnosed with or 
suspected of having lympho-proliferative disease or sarcoido-
sis were excluded. EBUS-TBNA was performed in patients 
with lung cancer without previous treatment with radiologi-
cally defined mediastinal and/or hilar LNs with a short axis of 
5 mm or more on enhanced chest computed tomography. The 
result of 18F-fluorodeoxy glucose-positron emission tomogra-
phy (FDG-PET) was also reviewed, and LNs with a standard-
ized uptake value more than 2.5 were considered as positive 
for malignancy. The definition of each LN location and cancer 
stage was based on the 7th edition of the TNM classification 
for lung cancer.12,13 This study was approved by the ethical 
committee at Chiba Cancer Center (No. 21-10).
Study Design
In this study, we compared benign and malignant EBUS 
Doppler-mode image findings in correlation with the pathol-
ogy of EBUS-TBNA samples to establish a standard EBUS 
Doppler-mode vascular image classification system. EBUS 
Doppler-mode images were reviewed carefully and images 
were categorized according to the morphological characteris-
tics of vessels inside and outside of the LN. This was based on 
previous results of Doppler-mode image analyses of primary 
tumor and LNs.8–11,14–16 
LN Observation Using EBUS
EBUS procedures were performed on an outpatient basis 
in patients under conscious sedation (midazolam) with local 
anesthesia. The CP-EBUS (BF-UC260FW; olympus Ltd., 
Tokyo, Japan) equipped with a linear probe on its tip was used 
to perform EBUS-TBNA for nodal staging. The ultrasound 
image was processed with the universal endoscopic ultrasound 
scanner (EU-ME1; olympus, Tokyo, Japan) at a frequency of 
10 MHz. Before Doppler-mode observation, conventional 
B-mode observation was performed, and the long and short 
axes of the LN were measured. The sonographic features on 
B-mode endosonography were categorized according to the 
previously published data as follows: shape, oval or round;, 
margin, indistinct or distinct; echogenicity, homogeneous or 
heterogeneous; and coagulation-necrosis sign, presence or 
absence.5 We measured both the long and the short axes of all 
LNs. When the ratio of the short to long axis of LNs was more 
than 1.5, we defined it as oval. If the majority of the margin 
(>50%) was clearly visualized with a high echoic border, we 
determined the LNs to be distinct. When we observed LNs 
by CP-EBUS, there existed echogenic differences between 
the LN and the surrounding connective-tissue structure. The 
coagulation-necrosis sign is a hypoechoic area within the 
LN without blood flow.5 The Power Doppler mode was first 
used, and then the Color Doppler mode was applied to each 
LN. Both Power and Color Doppler-mode images were cap-
tured as JPEG images at the maximum diameter of the LN. 
In addition, the Doppler-mode image was recorded by Digital 
Video format videotape, and the vascular findings reviewed 
by three different individuals (TN, TA, and Ky) blinded from 
the results of EBUS-TBNA. The final characteristics of the 
vascular findings for each LN were based on an agreement of 
at least two reviewers.
EBUS Doppler-Mode Image  
Characteristics of LNs
The Power Doppler mode is more sensitive for detecting 
blood-flow signals within the LN; therefore, we can visualize 
minimal blood flow by the Power Doppler mode. Conversely, 
the direction of blood flow can only be recognized by the use 
of Color Doppler mode. Blood flow going toward the ultra-
sound probe is visualized as red signal and blood flow going 
away from the probe is visualized as blue signal. 
Blood flow was visualized as red signals on the EBUS 
Power Doppler mode. The characteristics of the vascular struc-
ture within the LNs were graded based on the EBUS Power 
Doppler-mode images as follows (Fig. 1): Grade 0, no blood 
flow or small amounts of flow; Grade I, a few main vessels 
running toward the center of the LN from the hilum; Grade II: 
a few punctiform or rod-shaped flow signals, a few small ves-
sels found as a long strip of a curve; and Grade III, rich flow, 
more than four vessels found with different diameters and a 
twist or helical-flow signal. The blood flow arising from the 
bronchial artery (BA) toward the LN (away from the probe) 
was visualized as blue signals with pulse on EBUS color 
Doppler-mode image. The vascular finding running toward 
the LN from BA with pulse based on EBUS color Doppler-
mode images was defined as the BA inflow sign (Fig. 1). 
EBUS-TBNA
EBUS-TBNA was performed on each LN evaluated by 
the Doppler mode regardless of the findings of the ultrasound 
images. A dedicated 22-gauge needle was used to perform 
transbronchial needle aspiration (NA-201SX-4022; olympus, 
Tokyo, Japan) for LN sampling. EBUS-TBNA was performed 
FIGURE 1. EBUS Power/Color Doppler-mode image charac-
teristics of LNs. This figure shows the different EBUS Power/
Color Doppler-mode image characteristics used for the classi-
fication of LNs. (A), Grade 0: no blood flow or small amounts 
of flow, (B) Grade I: a few main vessels running toward the 
center of the LN from the hilum, (C) Grade II: a few puncti-
forms or rod-shaped flow signals, a few small vessels found as 
a long strip of a curve, (D) Grade III: rich flow, more than four 
vessels found with different diameters and twist or helical-
flow signal, (E) BA inflow sign: The blood flow from the BA 
toward the LN that was visualized as blue signals on EBUS 
Color Doppler-mode image. EBUS, endobronchial ultrasound; 
LN, lymph node; BA, bronchial artery.
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as previously described,17,18 but rapid on-site evaluation was 
not performed during this study. Cytological as well as his-
tological samples were sent for pathological diagnosis. In 
patients with malignant LNs, the determination was based 
on malignant cytologic and/or histologic results at EBUS-
TBNA or by surgical–pathologic confirmation. In patients 
with benign LNs, this determination was based on surgical–
pathologic confirmation of EBUS-TBNA targeted nodes by 
LN dissection of the LN station of interest, or from clinical 
follow-up for at least 6 months demonstrating a lack of clini-
cal or radiologic disease progression. All EBUS-TBNA were 
performed by two individuals (TN and MS) or under their 
supervision.
Data Analysis
All Doppler-image characteristics of the LNs were com-
pared to the final pathological/clinical results of the LNs. The 
sensitivity, specificity, positive predictive value (PPV), nega-
tive predictive value (NPV), and diagnostic accuracy rate were 
calculated by standard definitions. The intraobserver variabil-
ity was calculated by Cohen’s kappa method. The interobserver 
variability was calculated by Fleiss’s method to assess the kappa 
value of 3 independent interobserver variability.19 Statistical 
analyses were performed using R version 2.8.1 (R Foundation 
for Statistical Computing, http://www.r-project.org/).
RESULTS
Patients and Evaluated LNs
A total of 173 LNs were retrospectively evaluated in 100 
patients. There were 66 men and 34 women, and the average 
age was 65.5 years (36–83 years). The patients’ clinical stages 
were as follows: 13 stage IA; five stage-IB; four stage-IIA, two 
stage-IIB, 19 stage-IIIA, 10 stage-IIIB, and 47 stage-IV dis-
ease. There were no complications related to EBUS-TBNA.
The characteristics of the 173 LNs that were enrolled 
and evaluated in this study are summarized in Table 1. LN sta-
tions #4R, #7, and #11 were most frequently observed (137 in 
number and 79.2 % in proportion) and subjected to the analy-
sis. Size of the evaluated LNs ranged from 4.6 mm to 33.4 mm 
on EBUS image (11.96 mm on average). The number of LNs 
less than 1 cm and the number of nodes equal or greater than 
1 cm were 79 (45.7%) and 94 (54.3%), respectively. The cor-
relation among the vascular image patterns, LN size, and cell 
type is shown in Table 2.
The result of FDG-PET was available in 127 out of 
173 LNs. The number of LNs with a standardized uptake value 
less than 2.5, and equal to or more than 2.5 were 69 (54.3%) 
and 58 (45.7%), respectively. The sensitivity, specificity, and 
diagnostic accuracy rate of FDG-PET for the prediction of LN 
metastasis were 73.9%, 75.9%, and 74.8%, respectively.
EBUS B-mode Sonographic Features
The accuracy of predicting metastatic property by 
B-mode sonographic features was as high as 58.4% to 71.1% 
(71.1% for shape, 58.4% for margin, 64.2% for echogenic-
ity, and 65.3% for coagulation-necrosis sign). Eighty out of 
the 153 LNs (52.3%) having at least one metastatic feature 
of the four categories were pathologically proven metastatic. 
Twenty-five of 28 LNs (89.3%) were metastatic when all four 
categories were determined as metastatic, and 95.0% of LNs 
(19 of 20) were nonmetastatic when all four categories were 
determined as benign, vice versa.
TABLE 1. Characteristics of Evaluated Lymph Nodes
Lymph Node Station Station N
Hilum #11 47
#10 5
#12 1
Mediastinum #4R 47
#7 43
#4L 16
#2R 11
#3p 3
Size of lymph node CT EBUS
 Average (range) 12.7 mm (5–67) 12.0 mm 
(4.6–33.4)
Cell type n
Adenocarcinoma 53
Squamous cell carcinoma 12
Small cell carcinoma 11
Poorly differentiated cancer 5
Nonmetastatic lymph node 92
CT, computed tomography; EBUS, endobronchial ultrasound.
TABLE 2. Distribution of Vascular Structure Grade and BA 
Inflow Sign of Each Lymph Node Station, Size, and Cell Type
Station
Vascular Structure Grade BA Inflow Sign
Grade 0  
or I
Grade II or 
III Negative Positive
Hilum
 #11 (n = 47) 23 24 31 16
 #10 (n = 5) 1 4 2 3
 #12 (n = 1) 0 1 1 0
Mediastinum
 #4R (n = 47) 20 27 23 24
 #7 (n = 43) 18 25 23 20
 #4L (n = 16) 6 10 12 4
 #2R (n = 11) 5 6 5 6
 #3p (n = 3) 1 2 1 2
Size
 <10 mm 51 28 54 25
 ≥10 mm 23 71 44 50
Cell type
 Ad (n = 53) 8 45 16 37
 Sq (n = 12) 2 10 1 11
 SCLC (n = 11) 0 11 2 9
 p/d ca (n = 5) 0 5 0 5
BA, bronchial artery; Ad, Adenocarcinoma; Sq, Squamous cell carcinoma; 
SCLC, small cell lung cancer; p/d ca, poorly differentiated cancer.
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The Intraobserver and Interobserver 
Agreement of Doppler-Mode Image Findings
The Cohen’s kappa value to assess the intraobserver 
variability was 0.830 to 0.853, which was considered almost 
perfect agreement within the observer. The Fleiss’s kappa 
value of 3 interobserver variability was 0.83, which was con-
sidered almost perfect agreement for Power Doppler and Color 
Doppler-image interpretation.
Diagnostic Yield of Vascular Structure Grade of 
EBUS Power Doppler-Mode Image
Representative vascular structure findings of EBUS 
Power Doppler-mode images are shown in Figure 2. 
There were 74 Grade-0 LNs, 39 Grade-I LNs, 41 Grade -I LNs, 
and 58 Grade-III LNs (Table 2). The rate of metastatic LN was 
13.5% for Grade 0, 10.3% for Grade I, 61.0% for Grade II, 
and 79.3% for Grade III (Fig. 3). When we defined Grade 0 
and I as a benign character, and Grade II and III as a malignant 
character, the sensitivity, specificity, NPV, PPV, and diagnostic 
accuracy rate for the prediction of LN metastasis were 87.7%, 
69.6%, 71.7%, 86.5%, and 78.0%, respectively (Table 3). 
Diagnostic Yield of BA Inflow Sign of EBUS 
Color Doppler-Mode Image
A representative BA inflow sign of EBUS color Doppler-
mode images are shown in Figure 2. Ninety-eight LNs were 
judged as negative for BA inflow sign and 75 LNs were judged 
as positive for BA inflow sign (Table 2). The rate of metastatic 
LN was 20.4% for BA inflow sign negative LNs, and 81.3% 
for BA inflow sign positive LNs (Fig. 3). When we defined 
positive for BA inflow sign as a malignant character, the sen-
sitivity, specificity, NPV, PPV, and diagnostic accuracy rate for 
the prediction of LN metastasis were 75.3%, 84.8%, 81.3%, 
79.6%, and 80.3%, respectively (Table 4).
Diagnostic Yield of Integrate of Vascular 
Pattern Grade and BA Inflow Sign of EBUS 
Power/Color Doppler-Mode Image
Diagnostic yields for each feature are summarized in 
Figure 4. Seventy-four out of 173 LNs (42.8%) having a meta-
static feature in at least one of the two categories were patho-
logically proven to be metastatic. of the LNs 84.5% (49 out 
of 58) were metastatic when both two categories were deter-
mined as metastatic, and 84.7% of LNs (50 out of 57) were 
nonmetastatic when both two categories were determined 
as benign, vice versa (Fig. 4). The sensitivity, specificity, 
NPV, PPV, and diagnostic accuracy rate of integrated Power/
Color Doppler-mode interpretation for the prediction of LN 
metastasis were 83.1%, 89.3%, 86.2%, 86.0%, and 86.1%, 
respectively (n = 115).
The Test Characteristics of a Combined/
Integrated EBUS B-Mode, Power Doppler and 
Color Doppler Interpretation
To add the Doppler-mode image analysis (integrated 
Power Doppler and Color Doppler interpretation), the PPV 
of ultrasound image analysis for the prediction of metastatic 
LN rose from 89.3% to 95.0% (two out of three false positive 
result by B-mode analysis could be ruled out by Doppler-mode 
image analysis), and the NPV of ultrasound image analysis for 
the prediction of metastatic LN rose from 95.0% to 100% (one 
FIGURE 2. Representative Doppler-mode findings of EBUS 
images characteristics. (A) Grade 0, (B) Grade I, (C) Grade II, 
(D) Grade III, and (E) BA inflow sign. EBUS, endobronchial 
ultrasound; BA, bronchial artery.
FIGURE 3. EBUS Doppler-mode image classification and 
final diagnosis. The actual results of comparison between 
EBUS Doppler-mode image classification and final diagnosis. 
When LNs had been categorized as Grade 0 or I, and nega-
tive for BA inflow sign, they tended to be benign. Conversely, 
when LNs had been categorized as Grade II or III, and  
positive for BA inflow sign, they tended to be malignant,  
vice versa. EBUS, endobronchial ultrasound; LN, lymph node;  
BA, bronchial artery.
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false negative result by B-mode analysis could be ruled out by 
Doppler-mode image analysis).
DISCUSSION
Ultrasound Doppler-mode findings of malignant tumors 
are different from benign tumors,14–16 and can be used to dis-
tinguish between metastatic and nonmetastatic LN in patients 
with malignant diseases.8–11 In this study, we established a new 
standard EBUS Doppler-mode vascular image classification 
system, and showed a high diagnostic accuracy for predicting 
metastatic nodes using this classification system. In addition, 
this classification showed a high intraobserver and interob-
server agreement, which is considered to be almost perfect 
agreement (the Cohen’s kappa value to assess the intraobserver 
variability was 0.830–0.853, and the Fleiss’s kappa value of 3 
interobserver variability was 0.83).
Tissue diagnosis is often necessary in the management 
of lung cancer patients with mediastinal and hilar adenopa-
thy suspicious for metastasis. In addition, tissue obtained by 
EBUS-TBNA can be used for several molecular analyses, 
which can be useful for directing treatment.20–22 We have 
recently shown that sonographic EBUS features of LNs dur-
ing EBUS-TBNA are helpful for the prediction of benign LNs 
in lung cancer patients.5 The potential benefits of the previous 
study are in the NPV, and can help avoid unnecessary passes 
when rapid on-site cytology reveals only benign lymphocytes 
in LNs with benign ultrasound features. In fact, the sono-
graphic EBUS features showed a very high NPV of 95.0% in 
the current study. However, only 12.1% of the evaluated LNs 
demonstrated all four features suggestive of benign disease 
(the absence of round shape, distinct margin, heterogeneous 
echogenicity, and presence of coagulation-necrosis sign).
Vascular findings by Doppler-mode echogram are 
reported to better reflect local tissue perfusion and tissue 
oxygenation.23 Interestingly, the amount of blood flow or the 
vascularity index is related to the expression of angiogenesis-
related proteins such as vascular endothelial growth factor in 
gastric cancer10 and breast cancer.24 Furthermore, Doppler-
image findings correlate with poor prognosis in some malig-
nancies.10,15 EBUS Doppler-mode image analysis of metastatic 
LNs may also relate with the character of metastatic tumor 
cells; hence, this analysis may provide us additional informa-
tion about tumors. 
In our current study, we electively did not include 
patients with mediastinal and hilar adenopathy from noncan-
cerous diseases such as lymphoma and sarcoidosis. The echo 
features are quite different from metastatic findings detected 
in the previous study.5 We decided not to include this patient 
population, because the findings may confuse the interpreta-
tion of LNs in patients with lung cancer.
The limitation of our study is in the subjective inter-
pretation of the Doppler-mode image findings. To reduce 
technical biases, we made several efforts on Doppler-image 
interpretation as follows: (1) The frequency of the ultrasound 
probe was fixed at 10 MHz. (2) The Doppler-mode images can 
be easily varied by changing the angle of the ultrasound probe; 
therefore we captured the image at the maximum diameter of 
the LN to reduce this variability. (3) In addition, there was 
heterogeneity of vascular findings within the LN; therefore we 
also reviewed video clips of Doppler-mode observation, which 
was recorded by Digital Video format videotape. (4) To fur-
ther reduce the technical bias of EBUS Doppler observation, 
173 LNs were graded blindly by three different individuals 
(TN, TA, and Ky), and the final characteristics of the vascular 
findings for each LN were based on an agreement of at least 
two reviewers. By these efforts to reduce technical bias, we 
could achieve high intra- and interobserver agreement to clas-
sify the LNs. Another limitation of this study is that this is a 
TABLE 3. Result of Grading by Vascular Pattern (Grade II 
and III as Malignant) and Its Correlation With the Result of 
FDG-PET (SUV > 2.5 as Malignant)
EBUS Grade 
Final Diagnosis
Positive Negative
Positive 71 28 99
Negative 10 64 74
81 92 173
EBUS, endobronchial ultrasound; FDG-PET, 18F-fluorodeoxy glucose-positron 
emission tomography; SUV, standardized uptake value.
TABLE 4. Result of Classification by BA Inflow Sign (Inflow 
Finding as Malignant)
BA Inflow
Final Diagnosis
Positive Negative
Positive 61 14 75
Negative 20 78 98
81 92 173
BA, bronchial artery.
FIGURE 4. Overview of EBUS Doppler-mode image find-
ings and final diagnosis. Forty-nine of 58 LNs (87.5%) 
were metastatic when both categories were determined as 
“metastatic,” and 50 out of 57 LNs (84.7%) were nonmeta-
static when both categories were determined as “benign,” 
vice versa. (49 lymph nodes: Doppler positive, final positive; 
nine lymph nodes: Doppler positive, final negative; 50 lymph 
nodes: Doppler negative, final negative; and seven lymph 
nodes: Doppler negative, final positive). EBUS, endobronchial 
ultrasound; LN, lymph node.
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retrospective analysis. A prospective trial based on this vascu-
lar classification system will be warranted to confirm the util-
ity of Doppler-mode image findings to distinguish metastatic 
and nonmetastatic LNs.
In conclusion, by the use of vascular image pattern 
classification of LN using Doppler-mode ultrasound dur-
ing EBUS-TBNA we may predict the metastasis of LNs in 
patients with lung cancer. The combination of ultrasonog-
raphy features and a representative needle aspiration of 
lymphocytes may achieve more accurate mediastinal stag-
ing compared to EBUS-TBNA alone without the surgical 
staging modality. Conversely, blood-flow signals by Power 
Doppler mode, other than central intranodal blood flow and 
BA inflow signal from the bronchial lumen by color Doppler 
mode, are predictive factors for nodal metastasis. When such 
features are observed during EBUS, subsequent needle aspi-
ration should be performed. 
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